Detalhe da pesquisa
1.
Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation.
Proteomics
; 17(5)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28058811
2.
The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.
Proteomics
; 16(10): 1474-85, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27030549
3.
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera.
J Proteome Res
; 15(4): 1230-42, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26958999
4.
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.
Mol Cell Proteomics
; 13(7): 1814-27, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24742827
5.
Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.
J Proteome Res
; 14(3): 1627-36, 2015 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25611981
6.
Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches.
J Proteome Res
; 12(10): 4627-41, 2013 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23957277
7.
Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue.
J Mammary Gland Biol Neoplasia
; 17(2): 155-64, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22644111
8.
Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.
Mol Cell Proteomics
; 8(6): 1278-94, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19329653
9.
High-throughput proteomics of breast carcinoma cells: a focus on FTICR-MS.
Expert Rev Proteomics
; 5(3): 445-55, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18532912
10.
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.
Sci Rep
; 7(1): 2099, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522855
11.
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
Drug Discov Today
; 21(7): 1181-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27233379
12.
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.
Oncotarget
; 7(3): 3098-110, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26657294
13.
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
Mol Oncol
; 10(1): 24-39, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26285647
14.
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Sci Rep
; 6: 32027, 2016 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27558661
15.
Functional analysis of a novel androgen receptor mutation, Q902K, in an individual with partial androgen insensitivity.
J Clin Endocrinol Metab
; 90(1): 507-15, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15486055
16.
Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
Biochem J
; 379(Pt 3): 731-8, 2004 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14744261
17.
Shotgun proteomics on tissue specimens extracted with Acid guanidinium-thiocyanate-phenol-chloroform.
Methods Mol Biol
; 1293: 115-22, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26040684
18.
Antibody-based capture of target peptides in multiple reaction monitoring experiments.
Methods Mol Biol
; 1293: 123-35, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26040685
19.
Global proteomic characterization of microdissected estrogen receptor positive breast tumors.
Data Brief
; 5: 399-402, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26958599
20.
Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cells.
Cell Biosci
; 5: 10, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25774287